Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,329,000 | +61.6% | 138,514 | +34.7% | 0.02% | +27.8% |
| Q3 2019 | $2,679,000 | +14.0% | 102,800 | 0.0% | 0.02% | +12.5% |
| Q2 2019 | $2,351,000 | -12.7% | 102,800 | 0.0% | 0.02% | -5.9% |
| Q1 2019 | $2,694,000 | +28.8% | 102,800 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $2,091,000 | -47.5% | 102,800 | -31.5% | 0.02% | -34.6% |
| Q3 2018 | $3,984,000 | – | 150,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |